Inovio’s Voceryq Receives FDA Accelerated Approval
Inovio has secured accelerated approval from the FDA for Voceryq to minimise the frequency of…
Newswire
MHRA Promotes Yellow Card Reporting for MedSafetyWeek
The MHRA is encouraging patients, parents, carers, and healthcare professionals to report suspected side effects…
Kymera’s eczema trial readout could rival Dupixent
Kymera Therapeutics is set to announce data from a mid-stage clinical trial of its lead…
Gene Editing Stocks Surge on FDA Guidance and ESGCT Data
Shares of gene editing therapy companies surged by double digits recently, driven by two key…
Opentrons Secures $40M for Robotics and AI Expansion
Opentrons Labworks has raised $40 million from a Series E financing round led by healthcare…
Parse and Nomic Create 100 Million-Cell Dataset
Parse Biosciences, a QIAGEN company, and Nomic Bio have partnered to generate Cascade, a 100…
Building Resilience into Biologics Supply Chains
For biologics sponsors, true CDMO capacity depends on more than open slots—it requires the right…
IDWeek 2026: Phase III Trial Analysis of Ensitrelvir PEP
At IDWeek 2026, Akimasa Fukushi from Shionogi presented a subpopulation analysis of the Phase III…
David Liu Highlights Gene Editing Progress at ESGCT 2026
David Liu, PhD, emphasized the significant advancements in therapeutic genome editing during his plenary session…
Prediction Markets Raise Insider Trading Concerns for Biotechs
Legal experts warn that betting on pharmaceutical outcomes through platforms such as Kalshi and Polymarket…